Cronh’s Colitis

Cronh’s / Colitis

Those who suffer with these conditions experience diarrhea, bleeding, weight loss, anemia and abdominal pain.  Treatment focuses on symptom management and for some, requires bowel resection.  Treatment with hyperbaric oxygen has shown promise in the reduction of inflammation, alleviation of symptoms and an increased quality of life.   

It is especially noteworthy that many of the studies on Crohn's disease and ulcerative colitis used HBOT in patients who were not responding well to multiple medical treatments including corticosteroids, other medications and dietary changes. 


  • Normalize bowel movements
  • Alleviate symptoms
  • Decrease pain
  • Weight improvement


  • Decrease Edema
  • Lowers C-Reactive Protein
  • Decreases Pro-Inflammatory Cytokines


  • Immune regulation
  • Lower infection rate
  • Restore GI Flora
  • Mobilize Stem Cells
  • Increase blood flow to damaged tissues
  • Improve histopathological scores
  • Decrease oxidative stress

StudyHyperbaric oxygen treatment for inflammatory bowel disease: A systematic review and analysis

Thirteen studies of HBOT in Crohn's disease and 6 studies in ulcerative colitis were identified. In all studies, participants had severe disease refractory to standard medical treatments, including corticosteroids, immunomodulators and anti-inflammatory medications. In patients with Crohn's disease, 31/40 (78%) had clinical improvements with HBOT, while all 39 patients with ulcerative colitis improved

For access to additional research and case studies, become an IHA Member (link below)